“Breast Cancer Vaccine Shows Promise in Slowing Progress,” TIME.com

An initial safety trial of a breast cancer vaccine has proven safe, with preliminary results suggesting the vaccine will slow cancer progression. The vaccine, which is being developed by researchers at Washington University School of Medicine in St. Louis, is meant for patients with breast cancers that express a protein found only in breast tissue called mammaglobin-A. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is one of the 25 NCCN Member ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news